Structure-based Drug Design with Equivariant Diffusion Models
Schneuing, Arne, Du, Yuanqi, Harris, Charles, Jamasb, Arian, Igashov, Ilia, Du, Weitao, Blundell, Tom, Lió, Pietro, Gomes, Carla, Welling, Max, Bronstein, Michael, Correia, Bruno
–arXiv.org Artificial Intelligence
Structure-based drug design (SBDD) aims to design small-molecule ligands that bind with high affinity and specificity to pre-determined protein targets. In this paper, we formulate SBDD as a 3D-conditional generation problem and present DiffSBDD, an SE(3)-equivariant 3D-conditional diffusion model that generates novel ligands conditioned on protein pockets. Comprehensive in silico experiments demonstrate the efficiency and effectiveness of DiffSBDD in generating novel and diverse drug-like ligands with competitive docking scores. We further explore the flexibility of the diffusion framework for a broader range of tasks in drug design campaigns, such as off-the-shelf property optimization and partial molecular design with inpainting.
arXiv.org Artificial Intelligence
Jun-30-2023
- Country:
- Europe > United Kingdom
- England (0.28)
- North America > United States (0.92)
- Europe > United Kingdom
- Genre:
- Research Report (1.00)
- Technology: